Please use this identifier to cite or link to this item:
Title: nCVTs : a hybrid smart tumour targeting platform
Authors: Goh, Wei Jiang
Zou, Shui
Czarny, Bertrand
Pastorin, Giorgia
Keywords: Engineering::Materials
Issue Date: 2018
Source: Goh, W. J., Zou, S., Czarny, B., & Pastorin, G. (2018). nCVTs : a hybrid smart tumour targeting platform. Nanoscale, 10(15), 6812-6819. doi:10.1039/c7nr08720a
Journal: Nanoscale
Abstract: A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for a targeted approach towards tumour sites by preserving key surface proteins from U937 monocytes, while being amendable to functionalization and loading due to their liposomal components.
ISSN: 2040-3364
DOI: 10.1039/c7nr08720a
Rights: © 2018 The Royal Society of Chemistry. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:MSE Journal Articles

Citations 20

Updated on Feb 1, 2023

Web of ScienceTM
Citations 20

Updated on Feb 3, 2023

Page view(s)

Updated on Feb 5, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.